Favipiravir Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 200 mg
Reference Brands:
Category: Anti Covid Medicines
Favipiravir is available in Tablets and strengths such as 200 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Favipiravir is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Favipiravir can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Favipiravir should be taken orally at about the same time each day, either with or without food. Favipiravir tablets should be swallowed whole with water. The tablet should not be opened, broken, or chewed. For patients with COVID-19, the usual dosage of favipiravir for adults is 1800 mg orally twice daily on day 1, followed by 800 mg orally twice daily for 14 days.
Frequently Asked Questions
Related Products
Baricitinib
Strength: 2 mg, 4 mg
Form: Tablet
Reference Brands: Olumiant®(EU & US- Emergency Use Authorization (EUA)
View Details
Nirmatrelvir + Ritonavir
Strength: Nirmatrelvir(150 mg) + Ritonavir(100 mg)
Form: Tablet
Reference Brands: Paxlovid®(US & EU- For Emergency Use Authorization)
View Details
Tocilizumab
Strength: IV: 80 mg/4 mL, 200 mg/10 mL, 400 mg/20 mL; SQ: 162 mg/0.9 mL (pen or syringe)
Form: IV injection, SQ Injection
Reference Brands: Actemra®(US); RoActemra®(EU)
View Details
Quick Response Guaranteed | Verified Suppliers